Press Releases :: Avalo Therapeutics, Inc. (AVTX)

Mar 8, 2022 7:00 am EST

Avalo to Present at Oppenheimer's 32nd Annual Healthcare Conference

Mar 2, 2022 7:30 am EST

Avalo Therapeutics Reports 2021 Financial Results and Provides Business Updates

Feb 17, 2022 7:30 am EST

Avalo Therapeutics Announces Leadership Transition

Feb 7, 2022 4:01 pm EST

Avalo Therapeutics to Present at the 2022 BIO CEO and Investor Conference

Jan 10, 2022 7:58 pm EST

Avalo Therapeutics Appoints Stephen Smolinski as Chief Commercial Officer

Jan 6, 2022 7:30 am EST

Avalo Reports Positive Phase 1b Results for AVTX-002 in Moderate to Severe Crohn's Disease Patients and Presents Additional Program Updates at 2022 Investor Event

Dec 16, 2021 7:30 am EST

Avalo Therapeutics to Host Virtual Investor Day on January 6, 2022

Dec 6, 2021 7:30 am EST

Avalo Appoints Two New Independent Directors to Its Board

Nov 11, 2021 7:00 am EST

Avalo to Present at Two Upcoming Conferences

Nov 9, 2021 4:01 pm EST

Avalo Reports Third Quarter 2021 Financial Results and Provides Business Updates